The azole pharmacophore is still regarded as a viable lead structure for the synthesis of more effective antifungal agents [1] [2] [3] . In this study, new 2-substituted-N-[4-(1H-imidazole-1-yl) phenyl] acetamide (5a-5g, 6a-6n) derivatives were synthesized and the antifungal activities of these compounds were evaluated. The synthesized compounds consisted of two novel series of imidazole derivatives containing dithiocarbamate (5a-5g) and (benz) azolethiol (6a-6n) side chains that are structurally related to the famous antifungal azole pharmacophore. Their structures were characterized by spectral (IR, 1 H NMR, 13 C NMR, and MS spectra) analyses. The synthesized compounds were screened for in vitro antifungal activity against pathogenic strains of fungi. Theoretical ADME predictions were calculated for final compounds. A molecular docking study of the most active compound with target 'lanosterol 14α-demethylase' (CYP51) [4] was performed to unravel the mode of antifungal action.
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Compound 5e, which features imidazole and 4-methoxybenzyl piperazine scaffolds, showed the most promising antifungal activity with a MIC50 value of 0.78 ug/mL against Candida krusei. The effect of the compound 5e against ergosterol biosynthesis was observed by the LC-MS-MS method, which is based on quantification of the ergosterol level in C. krusei. Significant interactions were also observed between compound 5e and 14-α-sterol demethylase. In addition to good antifungal activity, all compounds in the series exhibited a good predicted pharmacokinetics profile.
